Medical Minute: Using Psychedelics In Psychiatry
Magic mushrooms are seen at the Procare farm in Hazerswoude, central Netherlands, Friday Aug. 3, 2007. Procare is the Netherlands’ largest grower of hallucinatory mushrooms, supplying more than half the market, a legal business in The Netherlands as long as they are sold fresh. It’s high season for tourists, but for many the emphasis is … Continued
Peter Dejong / Associated Press
In this “Medical Minute,” senior reporter Jim Burress and medical analyst Dr. Ford Vox talk about the growing research backing the use of psychedelics in psychiatry.
Drop out and tune in to this mind-altering segment.
For More Information:
- Role of psilocybin in the treatment of depression. Therapeutic Advances in Psychopharmacology. 2017 Jan; 7(1): 54–56.
- Psychedelics as Medicines: An Emerging New Paradigm. Clinical Pharmacology & Therapeutics. DOI: 10.1002/cpt.557
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology. 2016 Dec; 30(12): 1181-1197.
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of Psychopharmacology. 2016 Dec; 30(12): 1165-1180.
9(MDAxODM0MDY4MDEyMTY4NDA3MzI3YjkzMw004))
Top Stories
